Objectives: Pseudomonas aeruginosa exoproducts are potent triggers of immune responses in eukaryotic cells. Clarithromycin initially decreases, then increases and finally produces a sustained suppression of interleukin (IL)-8 secretion from normal human bronchial epithelial (NHBE) cells through inhibition and activation of extracellular signal-regulated kinase (ERK). This polyphasic immune response is referred to as immunomodulation.
Introduction
Pseudomonas aeruginosa is an opportunistic pathogen that accounts for much of the morbidity in persons with cystic fibrosis (CF) and diffuse panbronchiolitis (DPB). A number of bacterial virulence factors, including flagellin, alginate and lipopolysaccharide (LPS), can increase the production of inflammatory mediators by airway epithelial cells. Flagellin, the major structural protein of the bacterial flagellum, is a potent trigger of innate immune responses in eukaryotic cells 1 and is important in initiating inflammatory responses during pulmonary infection in vivo and in vitro.
2,3
Interleukin (IL)-8, a potent neutrophil-activating chemokine, is produced in airway cells after stimulation by Pseudomonas gene products. 4 Increased IL-8 in sputum and bronchoalveolar lavage fluid is associated with the severity of airway inflammation in CF and DPB. The extracellular signal-regulated kinase (ERK), p38 mitogen-activated protein kinase (MAPK) and c-jun N-terminal kinase (JNK) activation can increase IL-8 expression.
Long-term use of the 14-and 15-member macrolide antibiotics such as clarithromycin, erythromycin and azithromycin can decrease IL-8 production from airway cells 5 and are routinely used to treat CF and DPB, but their mechanism(s) of action are not fully elucidated. We have reported that macrolide antibiotics have a significant and non-linear (or chaotic, in mathematical terms) effect on IL-8 secretion from normal human bronchial epithelial (NHBE) cells. This suppression, followed by increased activation and finally a sustained suppression of IL-8 secretion in response to clarithromycin, has been termed immunomodulation and is probably dependent on the ERK pathway. 6 Alginate is an exopolysaccharide produced by mucoid P. aeruginosa isolates. Although both flagellin and alginate are thought to induce IL-8 secretion, these stimuli have not been directly compared in primary NHBE cultures. We compared these stimuli and evaluated whether stimulated IL-8 secretion was modulated by clarithromycin or dexamethasone. We also assessed the upstream kinase cell signalling intermediates that appear to be responsible for flagellin-induced IL-8 secretion.
Materials and methods

Reagents
Clarithromycin was donated by Abbott Labs (Abbott Park, IL, USA). LPS (10 mg/L, Escherichia coli serotype 0111: B4), dimethyl sulphoxide (DMSO), anti-b-actin, anti-mouse-IgG-HRP and dexamethasone were purchased from Sigma Chemical Co. (St Louis, MO, USA). SP600125, a JNK-II inhibitor, PD98059, an MAP kinase/ERK kinase (MEK: an upstream kinase of ERK1/2) inhibitor, and SB203580, a p38 inhibitor, were purchased from Calbiochem (La Jolla, CA, USA). Phospho-and non-phospho-specific anti-p42/ 44 MAPK, and anti-I-kB-a as well as anti-rabbit-IgG horseradish peroxidase (HRP) antibodies, were purchased from Cell Signaling Technology Inc. (Beverly, MA, USA). Kinase inhibitors were dissolved in DMSO before use.
NHBE cell culture
NHBE cells (Cambrex Bio Science; Walkersville, MD, USA) were plated at 3500 cells/cm 2 in culture dishes in bronchial epithelial cell growth medium (BEGM) supplemented with 52 mg/L bovine pituitary extract, 0.5 mg/L hydrocortisone, 0.5 pg/mL human recombinant epidermal growth factor, 0.5 mg/L epinephrine, 10 mg/L transferrin, 5 mg/L insulin, 0.1 ng/mL retinoic acid and 6.5 ng/mL triiodothyronine without antibiotics and cultured at 378C in a 5% CO 2 incubator. Endotoxin-free media were used (,0.005 EU/mL). We used second passage cells for all experiments. NHBE cells were routinely cultured on 25 cm 2 culture flasks coated with Type 1 rat-tail collagen (Sigma). The medium was changed at day 1 and subsequently every 48 h. The cells were grown to confluence for 6 days. Cultures without antibiotics were then transferred to 6-well or 35 mm dishes and seeded at 2Â10 5 cells/well in order to reach confluence at 24 h. The medium was changed every 24 h. As growth factors can stimulate IL-8, cells were grown in supplement-free BEGM medium for 24 h before drug exposure. Culture supernatants were harvested, centrifuged and stored at 2708C until assayed. Cells were also cultured for 2 or 24 h following stimulation for western blot analysis. The cell number was counted using a haemocytometer and cell viability was assessed by Trypan Blue dye exclusion. Cell morphology was evaluated using a phasecontrast microscope (Olympus, Tokyo, Japan).
Flagellin purification
Flagellin was purified from P. aeruginosa ATCC 10145. P. aeruginosa flagellin was purified from overnight culture supernatants and then was further purified by using polymyxin B beads (Sigma-Aldrich) according to the manufacturer's instructions. Removal of endotoxin to ,0.06 endotoxin U/mL was verified by using the Limulus amebocyte lysate detection kit (BioWhittaker, Walkersville, MD, USA).
The Pseudomonas flagellin preparations used in this work were endotoxin-free. We have performed control experiments using Pseudomonas flagellin to stimulate HEK293 cells stably transfected with human TLR-2, and we observed no activation of this receptor using our different flagellin preparations. We have compared the effect of flagellin from different bacterial species, including P. aeruginosa and Salmonella typhimurium. The activity of flagellin from these two species, as measured by the capacity to induce pro-inflammatory responses and activation of TLR-5 receptor, is similar. 3 
Alginate purification
Alginate was purified from the Pseudomonas strain FRD1. Briefly, FRD1 was grown overnight at 378C in 3% tryptic soy broth medium. Following the addition of 1 volume of saline, alginate was precipitated from the supernatant of this mucoid culture by the addition of an equal volume of 2% cetylpyridinium chloride (Sigma-Aldrich). After centrifugation at 25 000 g for 30 min, the pellet was re-suspended in the initial volume of 1 M NaCl. Finally, alginate was precipitated by the addition of 1 volume of chilled isopropanol, re-suspended in PBS and quantified in a colorimetric assay using alginic acid (Sigma-Aldrich) to plot a standard curve.
Cell stimulation and inhibition
Clarithromycin was dissolved in DMSO at a final concentration of 3 mg/mL; dexamethasone was dissolved in DMSO media at 1:49 (DMSO:BEGM) at a final concentration of 5Â10 25 M. Solutions were stored at 2208C. The cells were exposed to clarithromycin (10 mg/L) or dexamethasone (10 26 M) once daily. These concentrations were chosen to match the reported mean therapeutic concentration in lung tissue. Flagellin or other test compounds were added to cultures 24 h before harvesting. The MEK inhibitor, PD98059 (10 mM), the p38 MAPK inhibitor, SB203580 (10 mM), or the JNK inhibitor II, SP600125 (10 mM), was added 30 min before exposure to flagellin.
Preliminary experiments showed that flagellin, alginate, LPS, clarithromycin, dexamethasone, DMSO and the inhibitors had no significant effect on cell counts or cell viability for up to 24 h at the concentrations used here (data not shown).
Measurement of IL-8
Following stimulation, culture supernatants were collected and centrifuged for 5 min at 200 g and stored at 2208C. Cytokine immunoreactivity was measured in culture supernatants by ELISA for IL-8 (Immunotech, France) with a detection limit of 8 pg/mL, according to the manufacturer's instructions. Optical density was measured at 450 nm on a microtitre plate reader (Spectra Max Plus; Molecular Devices Corporation, Sunnyvale, CA, USA). Software (Soft Max Pro version 2.0; Molecular Devices Corporation) was used to determine the concentrations by interpolation from standard curves. Final concentrations in each sample were calculated as the mean of the results at the sample dilution, yielding optical densities in the linear portion of the calibration curves.
Measurement of phospho-ERK1/2
The cells were washed twice with 2 mL cold PBS. After the supernatants were completely aspirated, the cells were lysed on ice in a modified radioimmunoprecipitation buffer (1% NP-40, 1% sodium deoxycholate, 150 mM NaCl, 10 mM Tris pH 7.5, 5 mM sodium pyrophosphate, 1 mM NaVO 4 , 5 mM NaF, 1 mg/L aprotinin, 1 mg/L leupeptin, 0.1 mM PMSF) for 15 min and then scraped from the dishes and collected into a tube. DNA was sheared by passing the lysate through a 27G needle. Insoluble material was removed by centrifugation at 20 000 g for 15 min at 48C. The protein concentration of the resulting supernatant was quantified by the DC protein assay (Bio-Rad, Hercules, CA, USA), and the lysate was stored at 2708C until used. Equal amounts of protein extracts were loaded on a 12% SDS-PAGE mini gel and transferred to a nitrocellulose membrane (Bio-Rad) by electroblotting overnight. Membranes were rinsed with distilled water, incubated for 1 h at room temperature in Tris-buffered saline (0.8% NaCl and 20 mM Tris pH 7.6) with 0.1% Tween 20 (TBS-T) with 5% non-fat dry milk to block non-specific interactions, rinsed twice and washed three times for 10 min with TBS-T. After washing, membranes were exposed overnight to the primary antibodies 1 mg/L phospho-( p-) p44/42 MAPK (Thr-202/ Tyr-204) rabbit polyclonal IgG (Cell Signaling Technology Inc.) at 48C in TBS-T, with 5% milk. The blots were then washed and incubated at room temperature for 2 h with the anti-rabbit IgG HRP secondary antibody. Subsequently, the membranes were washed again and antibody binding was detected using LumiGLO chemiluminescent substrate peroxide (Cell Signaling Technology Inc.).
Membranes were stripped with a stripping buffer (100 mM b-mercaptoethanol, 2% SDS, 62.5 mM Tris-HCl pH 6.7) for 30 min at 608C. The blots were washed twice with TBS-T and re-probed with anti-p44/42 MAPK antibodies, followed by anti-rabbit-IgG HRP secondary antibody. Blots were stripped again, and equivalent protein loading was confirmed by western blot using anti-human b-actin antibody, followed by anti-mouse IgG and HRP secondary antibody and detected by ECL (Amersham, Piscataway, NJ, USA). Western blot images were scanned and analysed using NIH Image J software (http://rsb.info.nih.gov/ij/, as accessed in December 2005).
Statistical methods
Results are expressed as the mean values + SD or SEM as indicated. Statistical analysis of data was performed using the StatView 5 statistics package (SAS Institute, Cary, NC, USA). Parametric testing was conducted after confirming that raw data were normally distributed. Data were analysed temporally and by drug exposure using ANOVA, and in comparison to a specific control using a twosided, unpaired t-test. Conventionally, P , 0.05 was considered significant.
Results
Effects of flagellin, alginate and endotoxin (LPS) on IL-8 release
To evaluate the effect of P. aeruginosa flagellin and alginate on IL-8 release, NHBE cell supernatants were harvested 24 h after exposure to 10 29 , 10 28 or 10 27 M flagellin or 40 or 80 mg/L alginate. We used LPS as a positive control for IL-8 secretion.
Flagellin dose-dependently increased IL-8 secretion at 24 h (Figure 1a) , whereas alginate did not stimulate IL-8 over control.
Temporal effects of clarithromycin on flagellin-induced IL-8 release over 24 h
We evaluated the time-dependent effect of clarithromycin 10 mg/L on flagellin-induced IL-8 secretion during the initial 24 h of exposure. Clarithromycin decreased flagellin-induced IL-8 at 9 h (P , 0.05), but not at 24 h compared with flagellin alone (Figure 1b, top panel) . By itself, clarithromycin initially decreased IL-8 secretion at 4 and 9 h (P , 0.05) and then increased IL-8 secretion above baseline at 18 and 24 h (P , 0.0001, Figure 1b , bottom panel).
Effect of clarithromycin, dexamethasone and inhibiting ERK1/2, p38MAPK or JNK on flagellin-induced IL-8 release
To evaluate the effect of clarithromycin and dexamethasone on flagellin-induced IL-8 secretion, NHBE cell supernatants were harvested 24 h after exposure to clarithromycin 10 mg/L, dexamethasone 10 26 M or both clarithromycin and dexamethasone, added to the media at the same time flagellin 10 28 M was added. At 24 h, dexamethasone inhibited IL-8 secretion in unstimulated cells by 27.7% (P , 0.001) and in flagellin-stimulated cells by 57.9% (P , 0.0001), whereas clarithromycin had no effect (Figure 1c) .
We examined the role of intracellular kinase signalling pathways in cells treated with flagellin by using the MEK inhibitor PD98059, p38 MAPK inhibitor SB203580 or the JNK inhibitor SP600125, each at 10 mM. Cells were treated with a kinase inhibitor 30 min before adding flagellin 10 28 M, and cell supernatants were harvested after 24 h. Pre-treatment with PD98059 (MEK inhibitor) decreased flagellin-induced IL-8 secretion by 47.7% (P , 0.0001) compared with control flagellin exposure and decreased basal IL-8 in the absence of flagellin by 27.9% compared with untreated control cells (P , 0.0001, Figure 1c ). SB203580 ( p38 MAPK inhibitor) slightly increased IL-8 secretion both with (P ¼ 0.23) and without flagellin (P , 0.001), and SP600125 (a selective inhibitor of JNK) also slightly increased IL-8 secretion both with (P ¼ 0.05) and without flagellin (P ¼ 0.21).
The combination of PD98059 and dexamethasone further decreased flagellin-induced IL-8 secretion by 81.8%. The combination significantly decreased IL-8 compared with PD98059 or dexamethasone alone (P , 0.001 for each) (Figure 1c ).
Clarithromycin inhibits flagellin-induced phospho-ERK at 60 min but induces ERK phosphorylation at 24 h
We have reported that clarithromycin initially inhibits phospho-ERK ( pERK) in unstimulated NHBE cells. 6 We therefore tested whether a 60 min exposure to clarithromycin would decrease flagellin-induced phosphorylation of ERK. Flagellin 10 28 M increased pERK at 2 h, but a 60 min exposure to clarithromycin decreased pERK induced by flagellin by 78.0%, as shown in Figure 2a .
After 24 h, ERK phosphorylation increased after flagellin exposure compared with control and clarithromycin further 29 , 10 28 or 10 27 M was 240 + 30, 400 + 50 or 770 + 60 pg/mL, respectively (P , 0.0001, compared with unstimulated secretion of IL-8 measured at 110 + 8 pg/mL). Alginate did not stimulate IL-8 over control. These experiments were repeated four times. Data are shown as mean + SD. ***P , 0.001 and ****P , 0.0001, compared with control. (b) The temporal effects of clarithromycin (CLR) on flagellin-induced IL-8 secretion over the initial 24 h of exposure. CLR 10 mg/L decreased flagellin-induced IL-8 at 9 h (P , 0.05) but not at 24 h compared with flagellin alone (top panel). Flagellin by itself caused a sustained increase in IL-8 secretion (bottom panel), whereas CLR by itself decreased IL-8 secretion at 4 h (P , 0.05) and then increased IL-8 at 18 and 24 h (P , 0.0001) (bottom panel). Growth factors were withdrawn from the culture medium 24 h before the CLR exposure. These experiments were repeated four times. Data are shown as mean + SEM. *P , 0.05, ****P , 0.0001, #P , 0.05, ##P , 0.01 and ####P , 0.0001, compared with controls. (c) Effect of CLR, dexamethasone (DEX) and kinase inhibitors on flagellin-induced IL-8 secretion. IL-8 concentration after flagellin 10 28 M stimulation is set at 100%, and the y-axis shows IL-8 secretion relative to this. Cell supernatants were harvested 24 h after exposure to CLR 10 mg/L, DEX 10 26 M or both CLR and DEX. CLR or DEX was added to the media at the same time as flagellin. At 24 h, DEX inhibited flagellin-induced IL-8 secretion, whereas CLR had no effect. Cells were treated with an inhibitor 30 min before adding flagellin 10 28 M. The cell supernatants were harvested 24 h after the flagellin exposure. PD98059 (MEK inhibitor) decreased IL-8. Neither SB203580 (p38 inhibitor) nor SP600125 (JNK inhibitor) had an effect on IL-8 secretion. The combination of PD98059 and DEX additively decreased flagellin-induced IL-8 secretion compared with PD98059 or DEX alone. These experiments were repeated four times. Data are shown as mean + SEM. *P , 0.05, ***P , 0.001 and ****P , 0.0001, compared with flagellin alone. ###P , 0.001 and ####P , 0.0001, compared with control. þþþP , 0.001, compared with the combination of flagellin and PD98059 or DEX.
increased flagellin-induced pERK (Figure 2b) . Dexamethasone had no effect on ERK phosphorylation.
Discussion
We report here that P. aeruginosa flagellin dose-dependently increases IL-8 release from NHBE cells, but P. aeruginosa alginate does not affect IL-8 secretion. Consistent with previous reports, 4 flagellin appears to be a potent IL-8 stimulator in lung epithelial cells. The importance of flagellin as a soluble virulence factor has been demonstrated by studies showing its potent pro-inflammatory effects.
1 Bacterial flagellin elicits a strong inflammatory programme in epithelial cells, including the production of IL-8, 4,7 iNOS expression and activity and NF-kB activation. 8 Furthermore, flagellin plays a role in triggering adaptive immune responses by stimulating chemokine secretion by epithelial cells and subsequent migration and maturation of dendritic cells 9 and by modulating T cell activation in vivo. Here we show that clarithromycin decreases flagellin-induced IL-8 secretion at 9 h but enhances secretion at 24 h, whereas dexamethasone suppression of IL-8 was still present at 24 h. IL-8 secretion is increased by activation of NF-kB. Dexamethasone decreases cytokine production, in part, through the Ikk-NF-kB pathway. We show here that dexamethasone decreases flagellin-induced IL-8 at 24 h by 57.9% and baseline IL-8 secretion by 27.7% in the absence of flagellin. This effect of dexamethasone is consistent with NF-kB inhibition.
IL-8 secretion is also increased by activation of MAPK. Flagellin increased ERK phosphorylation over 24 h, and PD98059, a specific inhibitor of MEK-1, inhibited flagellin-induced IL-8 secretion by 47.7%. PD98059 decreased baseline IL-8 secretion by 27.9% in the absence of flagellin and decreased IL-8 secretion by 17.5% from baseline in the presence of flagellin, although this was not statistically significant (P ¼ 0.12). These results suggest that P. aeruginosa flagellin stimulates IL-8 secretion in NHBE cells in part through ERK1/ 2. Both SB203580 ( p38 inhibitor) and SP600125 (JNK inhibitor) slightly increased IL-8 secretion with or without flagellin.
ERK can regulate IL-8 independently of NF-kB. As well, ERK can directly affect the phosphorylation of IkB-a through IKKa/b and thus activate NF-kB in human airway epithelial cells. We show here that the ERK inhibitor combined with dexamethasone additively decreased flagellin-induced IL-8 secretion compared with PD98059 or dexamethasone alone (P , 0.001), suggesting that both NF-kB and ERK pathways are independently involved in flagellin-induced IL-8 secretion in NHBE cells.
A 60 min exposure to clarithromycin initially decreased flagellin-stimulated ERK phosphorylation, but at 24 h, clarithromycin increased ERK phosphorylation by 154% above that induced by flagellin alone. Clarithromycin also initially 26 M for 24 h and evaluated by western blotting. ERK phosphorylation increased after flagellin exposure compared with control. CLR further increased flagellin-induced pERK, whereas DEX had no effect. Western blot experiments were repeated twice with similar results.
decreased flagellin-induced IL-8 secretion over 9 h but increased IL-8 at 24 h, and this was inhibited by PD98059. The time lag between the changes in MAPK and IL-8 protein levels is consistent with studies showing that pulmonary epithelial cells exposed to crystalline silica increase MAPK to a maximum at 30 min, whereas IL-8 release occurs 4-8 h later. 10 We propose that clarithromycin initially decreases pro-inflammatory cytokine secretion via ERK inhibition, but that clarithromycin later increases ERK signalling, perhaps because of cross-talk among signal transduction pathways or through negative feedback, and suppression of IL-8 secretion by dexamethasone probably occurs through different pathways.
